Literature DB >> 25092233

Validation of a brief Opioid Compliance Checklist for patients with chronic pain.

Robert N Jamison1, Marc O Martel2, Robert R Edwards2, Jing Qian3, Kerry Anne Sheehan2, Edgar L Ross2.   

Abstract

UNLABELLED: There has been a need for a brief assessment tool to determine compliance with use of prescribed opioids for pain. The purpose of this study was to develop and begin the validation of a brief and simple compliance checklist (Opioid Compliance Checklist [OCC]) for chronic pain patients prescribed long-term opioid therapy. A review of the literature of opioid therapy agreements led to a 12-item OCC that was repeatedly administered to 157 patients who were taking opioids for chronic pain and followed for 6 months. Validation of the OCC was conducted by identifying those patients exhibiting aberrant drug-related behavior as determined by any of the following: positive urine toxicology screen, a positive score on the Prescription Drug Use Questionnaire interview or Current Opioid Misuse Measure, and/or ratings by staff on the Addiction Behavior Checklist. Of the original 12 items, 5 OCC items appeared to best predict subsequent aberrant behaviors based on multivariate logistic regression analyses (cross-validated area under the receiver operating characteristic curve = .67). Although further testing is needed, these results suggest that the OCC is an easy-to-use, promising measure in monitoring opioid adherence among persons with chronic pain. PERSPECTIVE: This study presents validation of a brief 5-item compliance checklist for use with chronic pain patients prescribed long-term opioid therapy. This measure asks patients about aberrant drug-related behavior over the past month, and any positive response indicates problems with adherence with opioids. Further cross-validation testing is needed.
Copyright © 2014 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Substance abuse; aberrant drug behaviors; adherence; chronic pain; compliance; opioids

Mesh:

Substances:

Year:  2014        PMID: 25092233      PMCID: PMC4253010          DOI: 10.1016/j.jpain.2014.07.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  37 in total

1.  The opioid contract.

Authors:  Scott M Fishman; Paul G Kreis
Journal:  Clin J Pain       Date:  2002 Jul-Aug       Impact factor: 3.442

2.  Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Authors:  Robert N Jamison; Edgar L Ross; Edward Michna; Li Q Chen; Caroline Holcomb; Ajay D Wasan
Journal:  Pain       Date:  2010-03-23       Impact factor: 6.961

3.  Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.

Authors:  Edward Michna; Edgar L Ross; Wilfred L Hynes; Srdjan S Nedeljkovic; Sharonah Soumekh; David Janfaza; Diane Palombi; Robert N Jamison
Journal:  J Pain Symptom Manage       Date:  2004-09       Impact factor: 3.612

4.  Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).

Authors:  Stephen F Butler; Kathrine Fernandez; Christine Benoit; Simon H Budman; Robert N Jamison
Journal:  J Pain       Date:  2008-01-22       Impact factor: 5.820

5.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

6.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

7.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

8.  The Pain Disability Index: psychometric and validity data.

Authors:  R C Tait; C A Pollard; R B Margolis; P N Duckro; S J Krause
Journal:  Arch Phys Med Rehabil       Date:  1987-07       Impact factor: 3.966

9.  Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.

Authors:  Michael F Fleming; James Davis; Steven D Passik
Journal:  Pain Med       Date:  2008-08-18       Impact factor: 3.750

10.  Validation of the Brief Pain Inventory for chronic nonmalignant pain.

Authors:  Gabriel Tan; Mark P Jensen; John I Thornby; Bilal F Shanti
Journal:  J Pain       Date:  2004-03       Impact factor: 5.820

View more
  7 in total

1.  Evaluation of the Preliminary Validity of Misuse of Prescription Pain Medication Items from the Patient-Reported Outcomes Measurement Information System (PROMIS)®.

Authors:  Dokyoung Sophia You; Jennifer M Hah; Sophie Collins; Maisa S Ziadni; Ben W Domingue; Karon F Cook; Sean C Mackey
Journal:  Pain Med       Date:  2019-10-01       Impact factor: 3.750

Review 2.  Opioid Use Disorder Assessment Tools and Drug Screening.

Authors:  James Ducharme; Sean Moore
Journal:  Mo Med       Date:  2019 Jul-Aug

3.  Development of an opioid-related Overdose Risk Behavior Scale (ORBS).

Authors:  Enrique R Pouget; Alex S Bennett; Luther Elliott; Brett Wolfson-Stofko; Ramona Almeñana; Peter C Britton; Andrew Rosenblum
Journal:  Subst Abus       Date:  2017-01-23       Impact factor: 3.716

4.  Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations.

Authors:  Jennifer S Gewandter; Shannon M Smith; Robert H Dworkin; Dennis C Turk; Tong J Gan; Ian Gilron; Sharon Hertz; Nathaniel P Katz; John D Markman; Srinivasa N Raja; Michael C Rowbotham; Brett R Stacey; Eric C Strain; Denham S Ward; John T Farrar; Kurt Kroenke; James P Rathmell; Richard Rauck; Colville Brown; Penney Cowan; Robert R Edwards; James C Eisenach; McKenzie Ferguson; Roy Freeman; Roy Gray; Kathryn Giblin; Hanna Grol-Prokopczyk; Jennifer Haythornthwaite; Robert N Jamison; Marc Martel; Ewan McNicol; Michael L Oshinsky; Friedhelm Sandbrink; Joachim Scholz; Richard Scranton; Lee S Simon; Deborah Steiner; Kenneth Verburg; Ajay D Wasan; Kerry Wentworth
Journal:  Pain       Date:  2021-11-01       Impact factor: 7.926

5.  Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.

Authors:  Charles E Argoff; Daniel P Alford; Jeffrey Fudin; Jeremy A Adler; Matthew J Bair; Richard C Dart; Roy Gandolfi; Bill H McCarberg; Steven P Stanos; Jeffrey A Gudin; Rosemary C Polomano; Lynn R Webster
Journal:  Pain Med       Date:  2018-01-01       Impact factor: 3.750

6.  French-Canadian translation of a self-report questionnaire to monitor opioid therapy for chronic pain: The Opioid Compliance Checklist (OCC-FC).

Authors:  Clarice Poirier; Marc O Martel; Mélanie Bérubé; Aline Boulanger; Céline Gélinas; Line Guénette; Anaïs Lacasse; David Lussier; Yannick Tousignant-Laflamme; M Gabrielle Pagé
Journal:  Can J Pain       Date:  2020-03-02

7.  Influence of opioid-related side effects on disability, mood, and opioid misuse risk among patients with chronic pain in primary care.

Authors:  Robert N Jamison; Kathleen Dorado; Anna Mei; Robert R Edwards; Marc O Martel
Journal:  Pain Rep       Date:  2017-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.